U.S. stocks are rallying once again, with the Dow and S&P 500 Index (SPX) hitting a record highs. Among the names making big moves are biotech Proteostasis Therapeutics Inc (NASDAQ:PTI), oil-and-gas issue Oasis Petroleum Inc. (NYSE:OAS), and IT stock Helios and Matheson Analytics Inc (NASDAQ:HMNY). Here's a quick look at what's moving shares of PTI, OAS, and HMNY.
Up 165.5% today at $6.24, Proteostasis Therapeutics is by far the biggest percentage gainer on the Nasdaq today. The rally comes after the company yesterday announced positive trial results for its cystic fibrosis treatments. PTI is now trading above its 200-day moving average for the first time since March, though it's still well below its February peak of $16.67. Meanwhile, Leerink and Baird raised their respective price targets to $8 and $25. Most analysts are already bullish on the biotech stock, with all three covering brokerage firms issuing "strong buy" ratings.
Shares of Oasis Petroleum are down 15.1% today at $8.54, after the company announced a public stock offering of 32 million common shares to help fund the purchase of additional land in the Delaware Basin. This price action puts OAS back below the formerly supportive 50-day moving average and brings its 12-month deficit to 45.3%.
Meanwhile, analyst reactions today have been mixed. While SunTrust Robinson downgraded Oasis Petroleum to "hold" from "buy," RBC was one of three brokerage firms to raise its price target, setting the bar at $14, though the latter said the company's biggest hurdle will be execution in the Permian Basin.
In the options pits, traders were showing bullish expectations coming into today. This is according to the security's 10-day call/put volume ratio of 13.23 across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) -- though volume has been muted on an absolute basis.